Both total PSA (Q3, p=0.002; Q4, p<0.001) and high prostate cancer risk (Q3, p=0.004; Q4, p=0.001) were negatively associated with Q3 and Q4 of the CDAI quartiles. This evidence concerns the gene KLK3 and prostate carcinoma.